These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2717515)

  • 1. Application of mean residence-time concepts to pharmacokinetic systems with noninstantaneous input and nonlinear elimination.
    Cheng HY; Jusko WJ
    Pharm Res; 1989 Jan; 6(1):4-12. PubMed ID: 2717515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mean residence time concepts for pharmacokinetic systems with nonlinear drug elimination described by the Michaelis-Menten equation.
    Cheng HY; Jusko WJ
    Pharm Res; 1988 Mar; 5(3):156-64. PubMed ID: 3244627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination.
    Berezhkovskiy LM
    J Pharm Sci; 2004 Jun; 93(6):1628-40. PubMed ID: 15124219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mean residence time of drugs administered non-instantaneously and undergoing linear tissue distribution and reversible metabolism and linear or non-linear elimination from the central compartment.
    Cheng H
    Biopharm Drug Dispos; 1995 May; 16(4):259-67. PubMed ID: 7548775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mean residence times and distribution volumes for drugs undergoing linear reversible metabolism and tissue distribution and linear or nonlinear elimination from the central compartments.
    Cheng HY; Jusko WJ
    Pharm Res; 1991 Apr; 8(4):508-11. PubMed ID: 1871048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mean residence time of oral drugs undergoing first-pass and linear reversible metabolism.
    Cheng H; Jusko WJ
    Pharm Res; 1993 Jan; 10(1):8-13. PubMed ID: 8430064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A derivation of mean residence time.
    Becker R
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():15-6. PubMed ID: 1820869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between steady-state and single-dose plasma drug concentrations for pharmacokinetic systems with nonlinear elimination.
    Cheng HY; Jusko WJ
    Biopharm Drug Dispos; 1989; 10(5):513-28. PubMed ID: 2804255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationships between half-life (t1/2) and mean residence time (MRT) in the two-compartment open body model.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2004 May; 25(4):157-62. PubMed ID: 15108218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of moment analysis to nonlinear drug disposition described by the Michaelis-Menten equation.
    Chow AT; Jusko WJ
    Pharm Res; 1987 Feb; 4(1):59-61. PubMed ID: 3508531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of mean residence time to determine the magnitude of difference between rate constants and to calculate tmax in the Bateman equation.
    Volosov A; Bialer M
    Biopharm Drug Dispos; 1999 Jan; 20(1):3-9. PubMed ID: 10086832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mean residence time for drugs subject to enterohepatic cycling.
    Shepard TA; Lockwood GF; Aarons LJ; Abrahams ID
    J Pharmacokinet Biopharm; 1989 Jun; 17(3):327-45. PubMed ID: 2810071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug redistribution and mean transit time concepts for nonlinear pharmacokinetic systems.
    Cheng HY; Jusko WJ
    Biopharm Drug Dispos; 1991; 12(1):73-9. PubMed ID: 2039813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of sample pooling methods for determining AUC, AUMC and mean residence times in pharmacokinetic studies.
    Cheung BW; Cartier LL; Russlie HQ; Sawchuk RJ
    Fundam Clin Pharmacol; 2005 Jun; 19(3):347-54. PubMed ID: 15910659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mean residence time of drugs in pharmacokinetic systems with linear distribution, linear or nonlinear elimination, and noninstantaneous input.
    Cheng HY; Jusko WJ
    J Pharm Sci; 1991 Oct; 80(10):1005-6. PubMed ID: 1783996
    [No Abstract]   [Full Text] [Related]  

  • 16. Constant-rate intravenous infusion methods for estimating steady-state volumes of distribution and mean residence times in the body for drugs undergoing reversible metabolism.
    Cheng H; Jusko WJ
    Pharm Res; 1990 Jun; 7(6):628-32. PubMed ID: 2367330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volumes of distribution and mean residence time of drugs with linear tissue distribution and binding and nonlinear protein binding.
    Cheng H; Gillespie WR
    J Pharmacokinet Biopharm; 1996 Aug; 24(4):389-402. PubMed ID: 9044167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the accuracy of calculation of the mean residence time of drug in the body and its volumes of distribution based on the assumption of central elimination.
    Berezhkovskiy LM
    Xenobiotica; 2016; 46(6):477-82. PubMed ID: 26406808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Michaelis-Menten elimination kinetics: areas under curves, steady-state concentrations, and clearances for compartment models with different types of input.
    Wagner JG; Szpunar GJ; Ferry JJ
    Biopharm Drug Dispos; 1985; 6(2):177-200. PubMed ID: 4005396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-compartmental analysis of pharmacokinetic data after multiple intravenous and oral administration.
    Rohatagi S; Kan S; Derendorf H
    Pharmazie; 1997 Jul; 52(7):529-32. PubMed ID: 9266589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.